Among the effects of this class of drugs, slowing gastric emptying is the most notable concern for anaes thetists because of its potential increased risk of gastric regurgitation and subsequent pulmonary aspiration during induction of general anaesthesia
This will help minimise the risk of injection site reactions and infections
Similarly, liraglutide for diabetes (Victoza) starts at 0.6 mg daily, escalating to 1.2 mg and potentially 1.8 mg if needed, while liraglutide for weight management (Saxenda) follows a schedule from 0.6 mg to 3.0 mg daily (via 1.2 mg, 1.8 mg, and 2.4 mg steps)
Poor sleep quality, difficulty losing fat, reduced lean muscle, slow recovery, and patients who want to optimize their body's natural growth hormone release during sleep
Energy levels rise, and clothing begins to fit better week by week